Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. (Q45914110)
Jump to navigation
Jump to search
scientific article published on 25 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. |
scientific article published on 25 July 2012 |
Statements
1 reference
Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. (English)
1 reference
Quanrongzi Wang
1 reference
Tongfu Yu
1 reference
Yifeng Yuan
1 reference
Haiwen Zhuang
1 reference
Zhaojing Wang
1 reference
Xisheng Liu
1 reference
Min Feng
1 reference
25 July 2012
1 reference
1 reference
107
1 reference
4
1 reference
422-427
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference